Effects of treatment with Astragalus Membranaceus on function of rat leydig cells
BMC Complementary and Alternative Medicine, ISSN: 1472-6882, Vol: 15, Issue: 1, Page: 261
2015
- 19Citations
- 15Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations19
- Citation Indexes19
- 19
- CrossRef12
- Captures15
- Readers15
- 15
Article Description
Background: Astragalus membranaceus (AM) is a Chinese traditional herb which has been reported to have broad positive effects on many diseases, including hepatitis, heart disease, diabetes and skin disease. AM can promote cell proliferation, increase the activities of superoxide dismutase (SOD) and glutathione peroxidase (GPx), and inhibit apoptosis by regulating the transcription of proto-oncogenes controlling cell death. While AM is included in some commercially available "testosterone boosting supplements", studies directly testing ability of AM to modulate testosterone production are lacking. In the present study, we examined the effects of AM on Leydig cell function in vitro. Methods: Rat Leydig cells were purified and treated with AM at different concentrations (0 μg/mL, 10 μg/mL, 20 μg/mL, 50 μg/mL, 100 μg/mL and 150 μg/mL) and cell counting-8 (CCK-8) assay, Enzyme-linked immunosorbent assay, quantitative real time PCR and analysis of activities of SOD and GPx were done respectively. Results: Treatment with 100 μg/mL (P<0.05) and 150 μg/mL AM (P<0.01) significantly increased Leydig cell numbers. Treatment with AM (20 μg/mL, 50 μg/mL and 100 μg/mL) significantly increased testosterone production (P<0.01). In addition, increased Leydig cell SOD and GPx activities were observed in response to 20 μg/mL and 50 μg/mL AM treatment (P<0.01). Furthermore, expression of Bax mRNA was significantly decreased (P<0.01), and the ratio of Bcl-2/Bax mRNA was significantly increased in response to 20 μg/mL AM in the culture medium (P<0.05). Conclusions: Results supported a beneficial effect of AM on multiple aspects of rat Leydig cell function in vitro including testosterone production.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84938091509&origin=inward; http://dx.doi.org/10.1186/s12906-015-0776-3; http://www.ncbi.nlm.nih.gov/pubmed/26231491; https://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-015-0776-3; https://dx.doi.org/10.1186/s12906-015-0776-3; https://bmccomplementmedtherapies.biomedcentral.com/articles/10.1186/s12906-015-0776-3; https://bmccomplementmedtherapies.biomedcentral.com/counter/pdf/10.1186/s12906-015-0776-3; http://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-015-0776-3; http://link.springer.com/article/10.1186/s12906-015-0776-3/fulltext.html; https://link.springer.com/track/pdf/10.1186/s12906-015-0776-3; https://link.springer.com/articles/10.1186/s12906-015-0776-3; https://link.springer.com/article/10.1186/s12906-015-0776-3; http://www.biomedcentral.com/1472-6882/15/261; https://bmccomplementalternmed.biomedcentral.com/track/pdf/10.1186/s12906-015-0776-3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know